Interactions of the antitumor drug, etoposide, with reduced thiols in vitro and in vivo.

[1]  N. Haim,et al.  In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins. , 1987, Biochemical pharmacology.

[2]  N. Haim,et al.  Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26). , 1986, Biochemical and biophysical research communications.

[3]  D. Ross,et al.  Metabolism of diethylstilbestrol by horseradish peroxidase and prostaglandin-H synthase. Generation of a free radical intermediate and its interaction with glutathione. , 1985, The Journal of biological chemistry.

[4]  D. Ross,et al.  The generation and subsequent fate of glutathionyl radicals in biological systems. , 1985, The Journal of biological chemistry.

[5]  G. Kupfer,et al.  Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. , 1985, Biochemical pharmacology.

[6]  M. Brattain,et al.  Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. , 1985, Cancer research.

[7]  B. Kalyanaraman,et al.  Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16, 213): implications for mode of action. , 1985, Biochemical pharmacology.

[8]  R. Wittes,et al.  Etoposide (VP-16-213). Current status of an active anticancer drug. , 1985, The New England journal of medicine.

[9]  C. Myers,et al.  Irreversible binding of etoposide (VP-16-213) to deoxyribonucleic acid and proteins. , 1984, Biochemical pharmacology.

[10]  C. Nathan,et al.  Glutathione metabolism as a determinant of therapeutic efficacy: a review. , 1984, Cancer research.

[11]  M. Anderson,et al.  Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Boyd,et al.  Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity. , 1984, The Journal of pharmacology and experimental therapeutics.

[13]  R. Mason,et al.  Free radical metabolites of L-cysteine oxidation. , 1984, The Journal of biological chemistry.

[14]  M. Brattain,et al.  Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship. , 1984, Biochemistry.

[15]  B. Kalyanaraman,et al.  Free radical metabolism of VP-16 and inhibition of anthracycline-induced lipid peroxidation. , 1983, Biochemical pharmacology.

[16]  J. Ducore,et al.  Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. , 1983, Cancer research.

[17]  A. Meister,et al.  Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Nathan,et al.  Glutathione depletion sensitizes tumor cells to oxidative cytolysis. , 1982, The Journal of biological chemistry.

[19]  D. J. Reed,et al.  Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes. , 1981, Biochemical pharmacology.

[20]  H. Sies,et al.  Assessment of the kidney function in maintenance of plasma glutathione concentration and redox state in anaesthetized rats , 1979, FEBS letters.

[21]  L. Flohé,et al.  The fate of extracellular glutathione in the rat. , 1978, Biochimica et biophysica acta.

[22]  D. V. Von Hoff,et al.  VM 26 and VP 16–213: A comparative analysis , 1977, Cancer.

[23]  J. Loike,et al.  Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells. , 1976, Biochemistry.

[24]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[25]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[26]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[27]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[28]  E. Benfenati,et al.  Horseradish peroxidase/hydrogen peroxide-catalyzed oxidation of VP16-213. Identification of a new metabolite. , 1985, Chemico-biological interactions.

[29]  A. Wozniak,et al.  DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity. , 1983, Cancer research.

[30]  L. F. Chasseaud,et al.  The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. , 1979, Advances in cancer research.